Associations of saposin C, Src, and androgen receptor upregulate the expression and function of androgen receptor in human prostate cancer cells

Journal of Cellular Biochemistry

Volumn 112, Issue 3, 2011, Pages 818-828

  Ding, Yan ^a,b   Wang, Xiaoling ^a,c   Xu, Aihui ^a   Xu, Xia ^a   Tian, Keli ^a   Young, Charles Y F ^d   Yuan, Huiqing ^a  

^a SHANDONG UNIVERSITY   (China)

^b XI'AN JIAOTONG UNIVERSITY   (China)

^c THE SECOND HOSPITAL OF SHANDONG UNIVERSITY   (China)

^d DEPARTMENT OF UROLOGY   (United States)

Author keywords

Androgen receptor; Prostate carcinoma cells; Saposin C; Src

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; ANDROGEN RECEPTOR; G PROTEIN COUPLED RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 13; MITOGEN ACTIVATED PROTEIN KINASE 3; NEUROTROPHIC PEPTIDE; PROTEIN KINASE P60; SAPOSIN C; SPHINGOLIPID ACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CELL SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOSOL; DISEASE ASSOCIATION; ENZYME ACTIVITY; ENZYME INDUCTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; INTRACELLULAR SIGNALING; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; UPREGULATION;

CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; PROMOTER REGIONS, GENETIC; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; RECOMBINANT PROTEINS; SAPOSINS; SRC-FAMILY KINASES; TRANSCRIPTIONAL ACTIVATION;

EID: 79951796016     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22977     Document Type: Article

References (29)

1. Amorino GP, Parsons SJ. 2004. Neuroendocrine cells in prostate cancer. Crit Rev Eukaryot Gene Expr 14:287-300. (Pubitemid 40221058)
2. Campana WM, Hiraiwa M, O'Brien JS. 1998. Prosaptide activates the MAPK pathway by a G-protein-dependent mechanism essential for enhanced sulfatide synthesis by Schwann cells. FASEB J 12:307-314. (Pubitemid 28106778)
3. Chmelar R, Buchanan G, Need EF, Tilley W, Greenberg NM. 2006. Androgen receptor coregulators and their involvement in the development and progression of prostate cancer. Int J Cancer 120:719-733.
4. Craft N, Shostak Y, Carey M, Sawyers CL. 1999. A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase. Nat Med 5:280-285. (Pubitemid 29124362)
5. Culig Z. 2004. Androgen receptor cross-talk with cell signalling pathways. Growth Factors 22:179-184. (Pubitemid 39377910)
6. Debes JD, Tindall DJ. 2004. Mechanisms of androgen-refractory prostate cancer. N Engl J Med 351:1488-1490. (Pubitemid 39315314)
7. Desai SJ, Ma AH, Tepper CG, Chen HW, Kung HJ. 2006. Inappropriate activation of the androgen receptor by nonsteroids: Involvement of the Src kinase pathway and its therapeutic implications. Cancer Res 66:10449-10459. (Pubitemid 44799766)
8. Devlin HL, Mudryj M. 2009. Progression of prostate cancer: Multiple pathways to androgen independence. Cancer Lett 274:177-186.
9. Ding Y, Yuan HQ, Kong F, Hu XY, Ren K, Cai J, Wang XL, Young CY. 2007. Ectopic expression of neurotrophic peptide derived from saposin C increases proliferation and upregulates androgen receptor expression and transcriptional activity in human prostate cancer cells. Asian J Androl 9:601-609. (Pubitemid 47354662)
10. Fu M, Wang C, Wang J, Zhang X, Sakamaki T, Yeung YG, Chang C, Hopp T, Fuqua SA, Jaffray E, Hay RT, Palvimo JJ, Janne OA, Pestell RG. 2002. Androgen receptor acetylation governs trans activation and MEKK1-induced apoptosis without affecting in vitro sumoylation and trans-repression function. Mol Cell Biol 22:3373-3388. (Pubitemid 34453978)
11. Gregory CW, Fei X, Ponguta LA, He B, Bill HM, French FS, Wilson EM. 2004. Epidermal growth factor increases coactivation of the androgen receptor in recurrent prostate cancer. J Biol Chem 279:7119-7130. (Pubitemid 38248859)
12. Guo Z, Dai B, Jiang T, Xu K, Xie Y, Kim O, Nesheiwat I, Kong X, Melamed J, Handratta VD, Njar VC, Brodie AM, Yu LR, Veenstra TD, Chen H, Qiu Y. 2006. Regulation of androgen receptor activity by tyrosine phosphorylation. Cancer Cell 10:309-319. (Pubitemid 44512189)
13. Heinlein CA, Chang C. 2002. The roles of androgen receptors and androgen-binding proteins in nongenomic androgen actions. Mol Endocrinol 16:2181-2187. (Pubitemid 35155532)
14. Hobisch A, Eder IE, Putz T, Horninger W, Bartsch G, Klocker H, Culig Z. 1998. Interleukin-6 regulates prostate-specific protein expression in prostate carcinoma cells by activation of the androgen receptor. Cancer Res 58:4640-4645. (Pubitemid 28480629)
15. Ikonen T, Palvimo JJ, Kallio PJ, Reinikainen P, Janne OA. 1994. Stimulation of androgen-regulated transactivation by modulators of protein phosphorylation. Endocrinology 135:1359-1366. (Pubitemid 24307509)
16. Koochekpour S, Sartor O, Lee TJ, Zieske A, Patten DY, Hiraiwa M, Sandhoff K, Remmel N, Minokadeh A. 2004. Prosaptide TX14A stimulates growth, migration, and invasion and activates the Raf-MEK-ERK-RSK-Elk-1 signaling pathway in prostate cancer cells. Prostate 61:114-123. (Pubitemid 39244698)
17. Koochekpour S, Sartor O, Hiraiwa M, Lee TJ, Rayford W, Remmel N, Sandhoff K, Minokadeh A, Patten DY. 2005. Saposin C stimulates growth and invasion, activates p42/44 and SAPK/JNK signaling pathways of MAPK and upregulates uPA/uPAR expression in prostate cancer and stromal cells. Asian J Androl 7:147-158. (Pubitemid 41051420)
18. Koochekpour S, Lee TJ, Wang R, Culig Z, Delorme N, Caffey S, Marrero L, Aguirre J. 2007. Prosaposin upregulates AR and PSA expression and activity in prostate cancer cells (LNCaP). Prostate 67:178-189. (Pubitemid 46185321)
19. Kraus S, Gioeli D, Vomastek T, Gordon V, Weber MJ. 2006. Receptor for activated C kinase 1 (RACK1) and Src regulate the tyrosine phosphorylation and function of the androgen receptor. Cancer Res 66:11047-11054. (Pubitemid 44877005)
20. Kung HJ, Evans CP. 2009. Oncogenic activation of androgen receptor. Urol Oncol 27:48-52.
21. Lee LF, Guan J, Qiu Y, Kung HJ. 2001. Neuropeptide-induced androgen independence in prostate cancer cells: Roles of nonreceptor tyrosine kinases Etk/Bmx, Src, and focal adhesion kinase. Mol Cell Biol 21:8385-8397. (Pubitemid 33108599)
22. Lee LF, Louie MC, Desai SJ, Yang J, Chen HW, Evans CP, Kung HJ. 2004a. Interleukin-8 confers androgen-independent growth and migration of LNCaP: Differential effects of tyrosine kinases Src and FAK. Oncogene 23:2197-2205. (Pubitemid 38482534)
23. Lee TJ, Sartor O, Luftig RB, Koochekpour S. 2004b. Saposin C promotes survival and prevents apoptosis via PI3K/Akt-dependent pathway in prostate cancer cells. Mol Cancer 3:31.
24. Papatsoris AG, Karamouzis MV, Papavassiliou AG. 2007. The power and promise of "rewiring" the mitogen-activated protein kinase network in prostate cancer therapeutics. Mol Cancer Ther 6:811-889.
25. Poukka H, Karvonen U, Janne OA, Palvimo JJ. 2000. Covalent modification of the androgen receptor by small ubiquitin-like modifier 1 (SUMO-1). Proc Natl Acad Sci USA 97:14145-14150. (Pubitemid 32016544)
26. Roy-Burman P, Tindall DJ, Robins DM, Greenberg NM, Hendrix MJ, Mohla S, Getzenberg RH, Isaacs JT, Pienta KJ. 2005. Androgens and prostate cancer: Are the descriptors valid? Cancer Biol Ther 4:4-5.
27. Ueda T, Bruchovsky N, Sadar MD. 2002. Activation of the androgen receptor N-terminal domain by interleukin-6 via MAPK and STAT3 signal transduction pathways. J Biol Chem 277:7076-7085. (Pubitemid 34959964)
28. Yuan H, Gong A, Young CY. 2005. Involvement of transcription factor Sp1 in quercetin-mediated inhibitory effect on the androgen receptor in human prostate cancer cells. Carcinogenesis 26:793-801. (Pubitemid 41214342)
29. Yuan HQ, Kong F, Wang XL, Young CY, Hu XY, Lou HX. 2008. Inhibitory effect of acetyl-11-keto-beta-boswellic acid on androgen receptor by interference of Sp1 binding activity in prostate cancer cells. Biochem Pharmacol 75:2112-2121.